Log In
Print
BCIQ
Print
Print this Print this
 

Lamivudine/zidovudine

  Manage Alerts
Collapse Summary General Information
Company Mylan Inc.
DescriptionFixed dose combination of 2 nucleoside analog reverse transcriptase inhibitors
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV/AIDS
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today